FDA Clears Smart Watch to Detect Seizures, Manage Epilepsy FDA Clears Smart Watch to Detect Seizures, Manage Epilepsy

The FDA has cleared the first smart watch for seizure tracking and epilepsy management. The device uses advanced machine learning to identify convulsive seizures and send an alert via text and phone message to caregivers.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

Related Links:

Authors: Yang N, Yang RX, Wang AH, Zhang YQ Abstract OBJECTIVE: To investigate the effect of intestinal flora on the neural development of severe hyperbilirubinemia neonates. PATIENTS AND METHODS: The clinical data of 108 severe hyperbilirubinemia neonates admitted to the Dezhou People's Hospital from January 2015 through January 2018 were analyzed, and all newborns had a serum total bilirubin level> 342 μmol/L. Based on whether they suffered from neural development abnormalities, the neonatal patients were divided into the neural abnormality group (n=52) and the non-neural abnormality group (n=56). The u...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Medtronic is introducing in the United States its deep brain stimulation therapy (DBS) as an option for treating drug-resistant epilepsy. About a third of epilepsy patients don’t respond positively to existing drug regimens, leaving patients &...
Source: Medgadget - Category: Medical Devices Authors: Tags: Neurology Neurosurgery Source Type: blogs
Medtronic (NYSE:MDT) said today that it launched its Deep Brain Stimulation system intended for medically-refractory epilepsy in the U.S. The Fridley, Minn.-based company said that the first patient was implanted with the system at Atlanta’s Emory University. “At Medtronic, we have a long-standing commitment to helping patients with medically refractory epilepsy through DBS, and we continue to explore other treatments and solutions along the epilepsy treatment pathway. With the FDA approval, commercial launch, and policy updates from several health insurers, we are positioned to help more people than ever ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Featured Neuromodulation/Neurostimulation Medtronic Source Type: news
Conditions:   Stroke;   Post Stroke Seizure;   Post Stroke Epilepsy Intervention:   Sponsor:   Lviv National Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Organic, Including Symptomatic, Mental Disorders;   Substance Use;   Schizophrenia;   Mood [Affective] Disorders;   Neurotic, Stress-related and Somatoform Disorders;   Eating Disorder;   Disorders of Adult Personality and Behavior;   Mental Retardation;   Disorder of  Psychological Development;   Behavioural Disorder;   Hypertension;   Dyslipidemias;   Ischemic Heart Disease;   Atrial Fibrillation;   Heart ...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Stroke;   Post Stroke Seizure;   Post Stroke Epilepsy Intervention:   Sponsor:   Lviv National Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Organic, Including Symptomatic, Mental Disorders;   Substance Use;   Schizophrenia;   Mood [Affective] Disorders;   Neurotic, Stress-related and Somatoform Disorders;   Eating Disorder;   Disorders of Adult Personality and Behavior;   Mental Retardation;   Disorder of  Psychological Development;   Behavioural Disorder;   Hypertension;   Dyslipidemias;   Ischemic Heart Disease;   Atrial Fibrillation;   Heart ...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 19 February 2019Source: The Lancet NeurologyAuthor(s): Tony Kirby
Source: The Lancet Neurology - Category: Neurology Source Type: research
(UT Southwestern Medical Center) Study shows that acetate, an acid found in some foods, may help doctors intervene when seizures are imminent.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Epilepsy is a frequent neurological disorder with a prevalence of 6.38 per 1,000 persons [1] and approximately 5 million people have been diagnosed with epilepsy worldwide, according to the World Health Organization (WHO). Patients with epilepsy have a three-fold risk for psychiatric comorbidities compared to the general population [2]. Almost 20-22% of patients with epilepsy suffer from depression [2 –7], while its prevalence may reach 60% in patients with temporal lobe epilepsy [8,9].
Source: Seizure: European Journal of Epilepsy - Category: Neurology Authors: Source Type: research
More News: Brain | Epilepsy | Health | Learning | Neurology | Neurosurgery | Universities & Medical Training